{{Rsnum
|rsid=11572177
|Gene=CYP2C8
|Chromosome=10
|position=96797270
|Orientation=minus
|GMAF=0.2516
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 40.7 | 46.9 | 12.4
| HCB | 83.2 | 16.8 | 0.0
| JPT | 90.3 | 9.7 | 0.0
| YRI | 44.9 | 42.9 | 12.2
| ASW | 43.9 | 50.9 | 5.3
| CHB | 83.2 | 16.8 | 0.0
| CHD | 87.2 | 12.8 | 0.0
| GIH | 53.5 | 38.6 | 7.9
| LWK | 32.7 | 50.9 | 16.4
| MEX | 62.1 | 36.2 | 1.7
| MKK | 41.0 | 50.6 | 8.3
| TSI | 40.2 | 46.1 | 13.7
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs11572177
|Name_s=
|Gene_s=CYP2C8
|Feature=
|Evidence=PubMed ID:15618689
|Annotation=Variant was identified in a cohort of 54 Japanese individuals, who were administered the anti-arrhythmic drug amiodarone. (HapMap SNP)
|Drugs=amiodarone
|Drug Classes=
|Diseases=
|Curation Level=Curated
|PharmGKB Accession ID=PA161660845
}}

{{PMID Auto
|PMID=20042077
|Title=Genetic determinants of hair and eye colours in the Scottish and Danish populations.
|OA=1
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs11572177
|overall_frequency_n=32
|overall_frequency_d=128
|overall_frequency=0.25
|n_genomes=29
|n_genomes_annotated=0
|n_haplomes=33
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}